Tanja Morath

Platelet Reactivity After Clopidogrel Treatment Assessed With Point-of-Care Analysis and Early Drug-Eluting Stent Thrombosis

Dirk Sibbing, Siegmund Braun, Tanja Morath et al. · Journal of the American College of Cardiology · 2009 · 649 citations

Medicine, Hematology, Pharmacology +17

Cytochrome 2C19*17 Allelic Variant, Platelet Aggregation, Bleeding Events, and Stent Thrombosis in Clopidogrel-Treated Patients With Coronary Stent Placement

Dirk Sibbing, Werner Koch, Daniela Gebhard et al. · Circulation · 2010 · 583 citations

Medicine, Cardiology, Pharmacology +17

ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stenting

Stefanie Schüpke, Robert A. Byrne, Jurriën M. ten Berg et al. · European Heart Journal · 2015 · 429 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Cytochrome P450 2C19 loss-of-function polymorphism and stent thrombosis following percutaneous coronary intervention

Dirk Sibbing, Julia Stegherr, Wolfgang Latz et al. · European Heart Journal · 2008 · 417 citations · Full text

Medicine, Cardiology, Pharmacology +17

Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel

Tanja Morath, Julia Stegherr, Siegmund Braun et al. · Thrombosis and Haemostasis · 2009 · 398 citations

Medicine, Pharmacology, Pharmacotherapy +17